Category: BA.4 COVID

Therapeutic potential of convalescent plasma and hyperimmune immunoglobulins against SARS-CoV-2 BQ.1, BQ.1.1, and XBB variants

Posted on | Posted on John Murphy | Leave a Comment on Therapeutic potential of convalescent plasma and hyperimmune immunoglobulins against SARS-CoV-2 BQ.1, BQ.1.1, and XBB variants

Lorenza Bellusci, Hana Golding, and Surender Khurana Journal of Clinical Investigation Published 2023 – More infoView PDF  Convalescent plasma (CP) and hyperimmune intravenous immunoglobulins (IVIGs) are routinely used to treat patients with COVID-19. SARS-CoV-2 Omicron variants continue to evolve, generating multiple sublineages with increased transmissibility and antibody-escape mutations (1, 2). Several Omicron lineages that are currently circulating (BA.4, BA.5, […]

Vaccine Makers “Deceptive” Booster Campaign

Posted on | Posted on John Murphy | Leave a Comment on Vaccine Makers “Deceptive” Booster Campaign

Wall Street Journal January 23, 2023 Wall Street Journal editorial board member Allysia Finley has taken a flamethrower to vaccine makers over their “deceptive” campaign for bivalent Covid boosters, and slams several federal agencies for taking “the unprecedented step of ordering vaccine makers to produce them and recommending them without data supporting their safety or […]

Bivalent Covid-19 Vaccines — A Cautionary Tale .

Posted on | Posted on John Murphy | Leave a Comment on Bivalent Covid-19 Vaccines — A Cautionary Tale .

List of authors. Paul A. Offit, M.Dt of authors. Paul A. Offit, M.D New England Journal of Medicine January 23, 2023 in Wuhan, China. Two months later, the original strain of SARS-CoV-2, called the Wuhan-1 or ancestral strain, was isolated and sequenced. It was now possible to make a vaccine. All the vaccines, including the […]

Bivalent Covid-19 Vaccines — A Cautionary Tale.

Posted on | Posted on John Murphy | Leave a Comment on Bivalent Covid-19 Vaccines — A Cautionary Tale.

List of authors. Paul A. Offit, M.D New England Journal of Medicine January 23, 2023 in Wuhan, China. Two months later, the original strain of SARS-CoV-2, called the Wuhan-1 or ancestral strain, was isolated and sequenced. It was now possible to make a vaccine. All the vaccines, including the mRNA vaccines made by Pfizer–BioNTech and […]

What COVID-19 variants are going around in November 2022?

Posted on | Posted on John Murphy | Leave a Comment on What COVID-19 variants are going around in November 2022?

Authors: Nebraska Medicine November 1, 2022 There are currently more than 37,000 cases reported in the United States per day, with test positivity of 8.6%. When test positivity is above 5%, transmission is considered uncontrolled. There are more than 340 deaths per day, and hospitalizations have increased 8% over the last two weeks.  What COVID-19 variant […]

Omicron is considered a milder coronavirus, but scientists aren’t so sure

Posted on | Posted on John Murphy | Leave a Comment on Omicron is considered a milder coronavirus, but scientists aren’t so sure

Authors: Melissa Healy August 13, 2022 la times For more than two years, Cathy Baron and Sara Alicia Costa managed to duck the coronavirus. But despite their being fully vaccinated and boosted, the Omicron variant finally caught them. Baron is an actress and dance instructor who lives in Santa Monica. Costa is an architect in Austin, […]

Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection

Posted on | Posted on John Murphy | Leave a Comment on Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection

Authors: Julie Boucau, Ph.D. Caitlin Marino, B.S. Ragon Institute, Cambridge, MA James Regan, B.S. Brigham and Women’s Hospital, Boston, MA Rockib Uddin, B.S.Massachusetts General Hospital, Boston, MA Manish C. Choudhary, Ph.D.James P. Flynn, B.S. Brigham and Women’s Hospital, Boston, MA Geoffrey Chen, B.A.Ashley M. Stuckwisch, B.S. Josh Mathews, A.B. May Y. Liew, B.A. Arshdeep Singh, […]

Natural Immunity From Omicron Strong Against Virus Subvariants: Study

Posted on | Posted on John Murphy | Leave a Comment on Natural Immunity From Omicron Strong Against Virus Subvariants: Study

Authors: Zachary Stieber via The Epoch Times, UL 18, 2022 The protection afforded by surviving COVID-19 was strong against the latest virus subvariants, including the one currently dominant in the United States, scientists in Qatar found. People who were infected with Omicron, a variant of SARS-CoV-2, had 76.1 percent protection against symptomatic reinfection from BA.4 and BA.5 […]

VIRAL THREAT 

Posted on | Posted on John Murphy | Leave a Comment on VIRAL THREAT 

New Covid variant dubbed ‘Centaurus’ already ‘detected in 10 countries including UK and US’ Authors: Vanessa Chalmers U.S, Sun Jul 19 2022 BA.2.75, nicknamed Centaurus, was first detected and is spreading rapidly in India. It is a relative of Omicon, the original strains of which were shown to be more mild Covid illness (BA.1 and BA.2). […]

New coronavirus subvariants escape antibodies from vaccination and prior Omicron infection, studies suggest

Posted on | Posted on John Murphy | Leave a Comment on New coronavirus subvariants escape antibodies from vaccination and prior Omicron infection, studies suggest

Authors: Jacqueline Howard, CNN June 23, 2022 Omicron subvariants BA.4 and BA.5 appear to escape antibody responses among both people who had previous Covid-19 infection and those who have been fully vaccinated and boosted, according to new data from researchers at Beth Israel Deaconess Medical Center, of Harvard Medical School. However, Covid-19 vaccination is still expected […]